RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Revance Therapeutics Stock

Revance Therapeutics ROA 2024

Revance Therapeutics ROA

-0.68

Ticker

RVNC

ISIN

US7613301099

WKN

A1XD3D

In 2024, Revance Therapeutics's return on assets (ROA) was -0.68, a 10.56% increase from the -0.61 ROA in the previous year.

Revance Therapeutics Aktienanalyse

What does Revance Therapeutics do?

Revance Therapeutics Inc is a US-based biopharmaceutical company that specializes in the development and marketing of novel treatments in dermatology, neurology, and aesthetic medicine. The company was founded in 2002 and is headquartered in Newark, California. Translated: Revance Therapeutics Inc is a US-based biopharmaceutical company that specializes in the development and marketing of novel treatments in dermatology, neurology, and aesthetic medicine. The company was founded in 2002 and is headquartered in Newark, California. Revance Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Revance Therapeutics's Return on Assets (ROA)

Revance Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Revance Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Revance Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Revance Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Revance Therapeutics stock

What is the Return on Assets (ROA) of Revance Therapeutics this year?

The Return on Assets (ROA) of Revance Therapeutics is -0.68 undefined this year.

What was the ROA of Revance Therapeutics compared to the previous year?

The ROA of Revance Therapeutics has increased by 10.56% compared to the previous year.

What consequences do high ROA have for investors of Revance Therapeutics?

A high ROA is advantageous for investors of Revance Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Revance Therapeutics?

A low ROA can be unfavorable for investors of Revance Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Revance Therapeutics affect the company?

An increase in ROA of Revance Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Revance Therapeutics impact the company?

A reduction in the ROA of Revance Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Revance Therapeutics?

Some factors that can influence the ROA of Revance Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Revance Therapeutics important for investors?

The ROA of Revance Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Revance Therapeutics take to improve ROA?

To improve ROA, Revance Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Revance Therapeutics pay?

Over the past 12 months, Revance Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Revance Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Revance Therapeutics?

The current dividend yield of Revance Therapeutics is .

When does Revance Therapeutics pay dividends?

Revance Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Revance Therapeutics?

Revance Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Revance Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Revance Therapeutics located?

Revance Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Revance Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Revance Therapeutics from 11/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/24/2024.

When did Revance Therapeutics pay the last dividend?

The last dividend was paid out on 11/24/2024.

What was the dividend of Revance Therapeutics in the year 2023?

In the year 2023, Revance Therapeutics distributed 0 USD as dividends.

In which currency does Revance Therapeutics pay out the dividend?

The dividends of Revance Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Revance Therapeutics

Our stock analysis for Revance Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Revance Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.